Canaccord Genuity Research Analyst Matt Bottomley Discusses iAnthus, Aphria, MedReleaf
4,014 views · Published 20 April 2018 · 9:08 · Indexed 26 October 2026
Channel: Midas Letter · 2018 · Education
Canaccord Genuity Research Analyst Matt Bottomley is very focused on the cannabis sector in both the United States and Canada. But recent moves by U.S. politicians has him unabashedly excited about Canadian cannabis companies with U.S. operations. ************************ Check out our website: https://MidasLetter.com ************************ SUBSCRIBE to our YouTube: http://bit.ly/MidasLetterYoutube SUBSCRIBE to our Newsletter: http://bit.ly/MidasLetterNewsletter Download Our Podcast on iTunes: http://bit.ly/MidasLetterPodcast ************************ Follow Us on Twitter: http://bit.ly/MidasLetterTwitter Like Us on Instagram: http://bit.ly/MidasLetterInsta Like Us on Facebook: http://bit.ly/MidasLetterFacebook ************************
More from this channel
-
6:13
Green Relief Inc CEO Warren Bravo on Growing Cannabis Using Fish
-
6:53
Crown Mining Corp (CVE:CWM) Director on Partnerships and Permitting for California Copper Projects
-
6:42
GreenBank CEO Danny Wettreich on Investing in Ubique and Blockchain Evolution
-
0:12
Hey Welcome to MIdas Letter!
-
8:42
MedReleaf CEO Neil Closner on the Recent $100 Million Financing Deal
-
7:50
Paycase Financial CEO Joseph Weinberg on Bitcoin Technology for Overseas Transactions
-
6:54
Lexaria CEO Chris Bunka on the Latest Cannabinoid Patents With Big Potential Revenue Streams
-
6:13
NeutriSci is into Energy Tablets, THC, and Genie Bouchard!